Recombinant DNA Therapeutics — NEET Biology
📚 Practice ConceptThe recombinant DNA technological processes have made immense impact in the area of healthcare by enabling mass production of safe and more effective therapeutic drugs. Further, the recombinant therapeutics do not induce unwanted immunological responses as is common in case of similar products isolated from non-human sources. At present, about 30 recombinant therapeutics have been approved for human-use the world over. In India, 12 of these are presently being marketed.
Assertion (A): Recombinant therapeutics are preferred over traditional animal-derived products. Reason (R): Recombinant therapeutics commonly induce unwanted immunological responses unlike products from non-human sources.
View solution & NCERT explanation
Correct answer: C — If assertion is true but reason is false.
NCERT confirms recombinant therapeutics are preferred for medical use. However, NCERT states “The recombinant therapeutics do not induce unwanted immunological responses as is common in case of similar products isolated from non-human sources” - it’s non-human products that cause immune responses, not recombinant therapeutics. The Reason reverses this key advantage.
What does NCERT say about recombinant DNA technological processes?
Has this concept appeared in NEET?
Which chapter is this from?
Through deep analysis of NEET and NTA, 88 of 90 questions from the NEET 2026 paper were matched straight from the MedicNEET Biology question bank.
88/90MedicNEET's Biology question bank is built from the same NCERT lines NTA picks repeatedly. Not random MCQs — questions crafted exactly like NTA crafts them.